Facebook
Twitter
Google+
LinkedIn
Email
Matthew is a Chartered Patent Attorney and European Patent Attorney and heads up our Cambridge Biotechnology and Life Sciences Group.
Matthew specialises in the preparation and prosecution of patent applications in the biotechnology, pharmaceuticals, biologics and healthcare fields. He regularly provides due diligence and freedom-to-operate advice to his clients in various technical areas and has particular expertise in diagnostic technologies; specifically biomarkers, applications of next generation sequencing and personalised medicine, especially companion diagnostics, therapeutics including antibodies, vaccines and CAR-T, analyte detection technologies including bacterial detection, gene editing, fermentation processes, stem cell technologies and medical devices. He brings strategic and commercial advice to his clients and has extensive experience of supporting early stage companies seeking investment and development partners. He has also worked on a Patent Attorney’s Report for an Initial Public Offering of a pharmaceutical company specialising in plant derived medicines.
Matthew is highly experienced in developing drafting and prosecution strategies for key client portfolios worldwide. He regularly represents his clients in Oral Proceedings before the Opposition and Appeal Boards of the European Patent Office.
Matthew speaks and publishes on various aspects of biotechnology and healthcare patenting. He has an MA Cantab (Natural Sciences) from Cambridge University which focused on biochemistry, molecular cell biology, chemistry and plant sciences and enables Matthew to practice in a wide range of biochemical and chemical technology areas. He also has an MSci Biochemistry also from Cambridge University in which Matthew engineered protein isoforms of a splicing regulator protein. He has a postgraduate certificate in Intellectual Property Law from Queen Mary & Westfield College, University of London and was awarded the Chartered Institute of Patent Agents Drafting prize for his performance in the finals examination.
Memberships
BIA
CIPA
EPI
One Nucleus
Qualifications
Chartered UK Patent Attorney (awarded the Chartered Institute of Patent Attorneys Drafting prize)
European Patent Attorney
MA (Cantab) Natural Sciences, University of Cambridge
MSci Biochemistry, University of Cambridge
Sectors
Biofuels
Biologics
Diagnostics
Medical devices
Pharmaceuticals
Practice areas
Biochemistry
Biomarkers
Cancer immunotherapies
Companion diagnostics
Enzymatic detection
Epigenetics
Gene therapy
Microbiology
Molecular biology
Nucleic acid based technologies
Plant derived pharmaceuticals
Proteins and peptides therapeutics
RNAi in plants
Small molecule imaging agents
Testimonials
